Smith & Nephew plc logo
Smith & Nephew plc SNN
$ 28.87 0.63%
report update icon

Quarterly report 2025-Q4
added 05-06-2026

Smith & Nephew plc Financial Statements 2025-2011 | SNN

Annual Financial Statements Smith & Nephew plc

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

27.4 B 23 B 23.5 B 23.7 B 29.7 B 18.1 B 20.1 B 15.7 B 14.8 B 13.5 B 15 B 16 B 13.2 B 10.4 B 8.61 B

Shares

867 M 873 M 871 M 872 M 877 M 437 M 437 M 436 M 437 M 445 M 447 M 446 M 450 M 448 M 446 M

Historical Prices

31.6 26.3 27 27.1 33.9 41.4 46.1 35.9 33.8 27.6 29.9 31.3 24.8 19.4 16

Net Income

625 M 412 M 263 M 223 M 524 M 448 M 600 M 663 M 767 M 784 M 410 M 501 M 556 M 729 M 582 M

Revenue

- - - - - 4.56 B 5.14 B 4.9 B 4.76 B 4.67 B 4.63 B 4.62 B 4.35 B 4.14 B 4.27 B

Cost of Revenue

1.97 B 1.76 B 1.73 B 1.54 B 1.54 B 1.4 B 1.34 B 1.3 B 1.25 B 1.27 B 1.14 B - - - -

Gross Profit

4.19 B 4.05 B 3.82 B 3.68 B 3.67 B 3.16 B 3.8 B 3.61 B 3.52 B 3.4 B 3.49 B 3.46 B 3.25 B 3.07 B 3.13 B

Operating Income

794 M 657 M 425 M 450 M 593 M 295 M 815 M 863 M 934 M 801 M 628 M - - - -

Interest Expense

140 M 145 M 132 M 80 M 80 M 62 M 65 M 59 M 57 M 52 M 49 M - - - -

EBITDA

1.37 B 1.3 B 1.11 B 1.07 B 1.16 B 857 M 1.32 B 1.3 B 1.38 B 1.14 B 1.16 B 1.09 B 1.03 B 1.01 B 1.16 B

Operating Expenses

- - - - - 2.67 B 2.81 B 2.6 B 2.56 B 2.5 B 2.6 B 2.56 B 2.37 B 2.15 B 2.27 B

General and Administrative Expenses

3.1 B 3.1 B 3.06 B 2.88 B 2.72 B 387 M 403 M 367 M 351 M 314 M 369 M 464 M 451 M 443 M 2.1 B

All numbers in USD currency

Quarterly Income Statement Smith & Nephew plc

2025-Q4 2024-Q4 2023-Q4 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

867 M 873 M 871 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

625 M 412 M 263 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

1.97 B 1.76 B 1.73 B - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

4.19 B 4.05 B 3.82 B - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

794 M 657 M 425 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

140 M 145 M 132 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

1.37 B 1.3 B 1.11 B - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

3.1 B 3.1 B 3.06 B - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Smith & Nephew plc SNN
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Smith & Nephew plc plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Vapotherm Vapotherm
VAPO
- 6.72 % $ 34 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
- - $ 162 M franceFrance
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Natus Medical Incorporated Natus Medical Incorporated
NTUS
- 1.94 % $ 1.05 B usaUSA
Titan Medical Titan Medical
TMDI
- -26.32 % $ 19.6 M canadaCanada
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
SeaSpine Holdings Corporation SeaSpine Holdings Corporation
SPNE
- 0.28 % $ 270 M usaUSA
AxoGen AxoGen
AXGN
$ 48.28 2.51 % $ 2.22 B usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 58.5 0.13 % $ 8.88 B usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
$ 74.29 2.75 % $ 2.2 B costa-ricaCosta-rica
Nevro Corp. Nevro Corp.
NVRO
- - $ 217 M usaUSA
Abiomed Abiomed
ABMD
- - $ 17.2 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 108.33 0.19 % $ 189 B usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 1.82 6.04 % $ 1.23 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 6.49 1.09 % $ 877 M usaUSA
Align Technology Align Technology
ALGN
$ 158.64 0.03 % $ 11.5 B usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 3.05 0.32 % $ 125 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
$ 0.27 0.3 % $ 33.1 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 9.45 1.29 % $ 1.42 B usaUSA
Avanos Medical Avanos Medical
AVNS
$ 24.99 - $ 1.16 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Butterfly Network Butterfly Network
BFLY
$ 7.36 0.96 % $ 1.82 B usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
$ 386.11 0.05 % $ 10.5 B usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 47.8 1.83 % $ 70.8 B usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 8.47 0.71 % $ 618 M israelIsrael
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 13.96 0.67 % $ 395 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 49.32 0.02 % $ 1.53 B usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.35 0.03 % $ 21.8 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Delcath Systems Delcath Systems
DCTH
$ 16.48 1.1 % $ 590 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA